Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis
Neuroradiology · 2025
DOI: 10.1007/s00234-025-03663-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neuroradiology, 2025. Verfasst von Nogol Motamedgorji und 13 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Magnetic Resonance Imaging, Iron. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Iron rim lesions (IRLs) have emerged as important biomarkers in multiple sclerosis (MS), indicating chronic active inflammation and neurodegeneration. The purpose of this systematic review and meta-analysis is to assess the prognostic value of IRLs in MS, their impact on clinical outcomes, and their relationship with therapeutic responses. METHODS: A thorough search was conducted across PubMed, Scopus, Web of Science, and Google Scholar, covering studies published until June 10, 2024. The inclusion criteria included studies on MS patients who had IRLs detected using advanced MRI techniques, particularly susceptibility-weighted imaging (SWI). The meta-analysis included 13 studies and a total of 924 MS patients. The data on clinical outcomes (EDSS scores, relapse rates), brain volume, and white matter lesion (WML) burden were combined. For continuous variables, effect sizes were calculated using standardized mean differences (SMDs), and for binary outcomes, relative risks (RRs). RESULTS: This meta-analysis indicated significant correlations between IRLs and poorer clinical outcomes. IRL-positive individuals had higher EDSS scores (SMD 0.77, 95% CI: 0.34-1.21, p = 0.000), indicating a more severe impairment. They also had a larger WML load (SMD 0.52, 95% CI: 0.01-1.03, p = 0.000) and a smaller brain volume (SMD -0.50, 95% CI -0.82 to -0.19, p = 0.015). The relapse rate ratio was 1.10 (95% CI 0.73-1.65, p = 0.499), indicating a trend toward more frequent relapses in IRL-positive patients, though not statistically significant. Treatment response to disease-modifying treatments (DMTs) was similar in IRL-positive and negative individuals (RR 0.97, 95% CI: 0.89-1.06, p = 0.424). However, IRL-positive patients who received high-dose DMTs (HDMT) had a trend toward better outcomes (RR 1.2, 95% CI 0.94-1.52, p = 0.424). CONCLUSIONS: IRLs are strongly linked to higher disease severity, lesion burden, and neurodegeneration in MS patients. These lesions should be considered in routine medical evaluations since they are reliable prognostic indicators. Early intervention with high-dose treatment might offer potential benefits for IRL-positive patients, but further research is needed to determine the long-term clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.
- Department of Radiological Technologies, College of Health and Medical Technologies, University of Hilla, Babylon, Iraq.
- Department of Radiology Technology, Collage of Health and Medical Technology, Al-Ayen Iraqi University, Thi-Qar, 64001, Iraq.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
- Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Islamic Republic of Iran.
Zitieren
APA
Motamedgorji, N., Bahrami, A., Taher, H. J., Mohamedbaqer Easa, A., Salehi, S., Tafazolimoghadam, A., Farzan, M., Sadeghi, Z., Mofidinaeini, S., Hajibeygi, R., Khakpour, Y., Fathi, M., Zoghi, A., & Tu, L. H. (2025). Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis. Neuroradiology. https://doi.org/10.1007/s00234-025-03663-5
Vancouver
Motamedgorji N, Bahrami A, Taher HJ, Mohamedbaqer Easa A, Salehi S, Tafazolimoghadam A, et al. Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis. Neuroradiology. 2025. doi:10.1007/s00234-025-03663-5
BibTeX
@article{Motamedgorji2025,
author = {Motamedgorji, Nogol and Bahrami, Ashkan and Taher, Hayder Jasim and Mohamedbaqer Easa, Ahmed and Salehi, Sadaf and Tafazolimoghadam, Armin and Farzan, Mahan and Sadeghi, Zohreh and Mofidinaeini, Saharnaz and Hajibeygi, Ramtin and Khakpour, Yaser and Fathi, Mobina and Zoghi, Anahita and Tu, Long H},
title = {Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis},
journal = {Neuroradiology},
year = {2025},
doi = {10.1007/s00234-025-03663-5}
}
EUVIMED